Neuroleptic intolerance
This article reviews antipsychotic medication side effects, especially those that require the physician to discontinue or the patient to be noncompliant with otherwise useful medication. They include such common problems as extrapyramidal syndromes (dystonia, akathisia, drug-induced Parkinsonism, ta...
Gespeichert in:
Veröffentlicht in: | Schizophrenia bulletin 1997, Vol.23 (4), p.567-582 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 582 |
---|---|
container_issue | 4 |
container_start_page | 567 |
container_title | Schizophrenia bulletin |
container_volume | 23 |
creator | Hansen, T E Casey, D E Hoffman, W F |
description | This article reviews antipsychotic medication side effects, especially those that require the physician to discontinue or the patient to be noncompliant with otherwise useful medication. They include such common problems as extrapyramidal syndromes (dystonia, akathisia, drug-induced Parkinsonism, tardive dyskinesia), sedation, weight gain, and sexual dysfunction, as well as less frequent concerns, such as seizures, neuroleptic malignant syndrome, agranulocytosis, torsade de pointes, hepatitis, and dermatological and ophthalmological syndrome. The adverse events associated with some of the new antipsychotic drugs are included. Available information about individual susceptibility to side effects is addressed by syndrome. |
doi_str_mv | 10.1093/schbul/23.4.567 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_614326033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>614326033</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-94e89e0c9613cdb24a86123fc0196134beb222b013ccc217498c3d7ec379359b3</originalsourceid><addsrcrecordid>eNo9ULFOwzAQtRColMLcCQmxJ7F9jh2PqKKAVMECsxVfHJEqTYKdDPw9rhIx3enu3XvvHiFbRlNGNWQBv-3UZhxSkeZSXZA1UyJPmKLskqxpXshESSauyU0IR0qZ0JKvyEqDzLWWa7J9d5PvWzeMDT403RhbX3bobslVXbbB3S11Q772z5-71-Tw8fK2ezokCJKOiRau0I6ilgywslyUhWQcaqTsPBLWWc65pXGLyKM1XSBUyiEoDbm2sCGPM-_g-5_JhdEc-8l3UdJE28AlBYigbAah70PwrjaDb06l_zWMmnMMZo7BcDDCxBjixf1CO9mTq_7xy9_wBwb-V3k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>614326033</pqid></control><display><type>article</type><title>Neuroleptic intolerance</title><source>MEDLINE</source><source>Oxford Academic Journals (OUP)</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>EBSCOhost APA PsycARTICLES</source><creator>Hansen, T E ; Casey, D E ; Hoffman, W F</creator><creatorcontrib>Hansen, T E ; Casey, D E ; Hoffman, W F</creatorcontrib><description>This article reviews antipsychotic medication side effects, especially those that require the physician to discontinue or the patient to be noncompliant with otherwise useful medication. They include such common problems as extrapyramidal syndromes (dystonia, akathisia, drug-induced Parkinsonism, tardive dyskinesia), sedation, weight gain, and sexual dysfunction, as well as less frequent concerns, such as seizures, neuroleptic malignant syndrome, agranulocytosis, torsade de pointes, hepatitis, and dermatological and ophthalmological syndrome. The adverse events associated with some of the new antipsychotic drugs are included. Available information about individual susceptibility to side effects is addressed by syndrome.</description><identifier>ISSN: 0586-7614</identifier><identifier>EISSN: 1745-1701</identifier><identifier>DOI: 10.1093/schbul/23.4.567</identifier><identifier>PMID: 9365996</identifier><language>eng</language><publisher>United States: National Institute of Mental Health</publisher><subject>Antipsychotic Agents - adverse effects ; Drug Therapy ; Dyskinesia, Drug-Induced - etiology ; Extrapyramidal Symptoms ; Human ; Humans ; Neuroleptic Drugs ; Neuroleptic Malignant Syndrome - etiology ; Parkinson Disease, Secondary - chemically induced ; Patient Compliance ; Schizophrenia - drug therapy ; Seizures - chemically induced ; Sexual Dysfunctions, Psychological - chemically induced ; Side Effects (Drug) ; Torsades de Pointes - chemically induced</subject><ispartof>Schizophrenia bulletin, 1997, Vol.23 (4), p.567-582</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-94e89e0c9613cdb24a86123fc0196134beb222b013ccc217498c3d7ec379359b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9365996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hansen, T E</creatorcontrib><creatorcontrib>Casey, D E</creatorcontrib><creatorcontrib>Hoffman, W F</creatorcontrib><title>Neuroleptic intolerance</title><title>Schizophrenia bulletin</title><addtitle>Schizophr Bull</addtitle><description>This article reviews antipsychotic medication side effects, especially those that require the physician to discontinue or the patient to be noncompliant with otherwise useful medication. They include such common problems as extrapyramidal syndromes (dystonia, akathisia, drug-induced Parkinsonism, tardive dyskinesia), sedation, weight gain, and sexual dysfunction, as well as less frequent concerns, such as seizures, neuroleptic malignant syndrome, agranulocytosis, torsade de pointes, hepatitis, and dermatological and ophthalmological syndrome. The adverse events associated with some of the new antipsychotic drugs are included. Available information about individual susceptibility to side effects is addressed by syndrome.</description><subject>Antipsychotic Agents - adverse effects</subject><subject>Drug Therapy</subject><subject>Dyskinesia, Drug-Induced - etiology</subject><subject>Extrapyramidal Symptoms</subject><subject>Human</subject><subject>Humans</subject><subject>Neuroleptic Drugs</subject><subject>Neuroleptic Malignant Syndrome - etiology</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Patient Compliance</subject><subject>Schizophrenia - drug therapy</subject><subject>Seizures - chemically induced</subject><subject>Sexual Dysfunctions, Psychological - chemically induced</subject><subject>Side Effects (Drug)</subject><subject>Torsades de Pointes - chemically induced</subject><issn>0586-7614</issn><issn>1745-1701</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9ULFOwzAQtRColMLcCQmxJ7F9jh2PqKKAVMECsxVfHJEqTYKdDPw9rhIx3enu3XvvHiFbRlNGNWQBv-3UZhxSkeZSXZA1UyJPmKLskqxpXshESSauyU0IR0qZ0JKvyEqDzLWWa7J9d5PvWzeMDT403RhbX3bobslVXbbB3S11Q772z5-71-Tw8fK2ezokCJKOiRau0I6ilgywslyUhWQcaqTsPBLWWc65pXGLyKM1XSBUyiEoDbm2sCGPM-_g-5_JhdEc-8l3UdJE28AlBYigbAah70PwrjaDb06l_zWMmnMMZo7BcDDCxBjixf1CO9mTq_7xy9_wBwb-V3k</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>Hansen, T E</creator><creator>Casey, D E</creator><creator>Hoffman, W F</creator><general>National Institute of Mental Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope></search><sort><creationdate>1997</creationdate><title>Neuroleptic intolerance</title><author>Hansen, T E ; Casey, D E ; Hoffman, W F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-94e89e0c9613cdb24a86123fc0196134beb222b013ccc217498c3d7ec379359b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antipsychotic Agents - adverse effects</topic><topic>Drug Therapy</topic><topic>Dyskinesia, Drug-Induced - etiology</topic><topic>Extrapyramidal Symptoms</topic><topic>Human</topic><topic>Humans</topic><topic>Neuroleptic Drugs</topic><topic>Neuroleptic Malignant Syndrome - etiology</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Patient Compliance</topic><topic>Schizophrenia - drug therapy</topic><topic>Seizures - chemically induced</topic><topic>Sexual Dysfunctions, Psychological - chemically induced</topic><topic>Side Effects (Drug)</topic><topic>Torsades de Pointes - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hansen, T E</creatorcontrib><creatorcontrib>Casey, D E</creatorcontrib><creatorcontrib>Hoffman, W F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PsycArticles (via ProQuest)</collection><collection>ProQuest One Psychology</collection><jtitle>Schizophrenia bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hansen, T E</au><au>Casey, D E</au><au>Hoffman, W F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroleptic intolerance</atitle><jtitle>Schizophrenia bulletin</jtitle><addtitle>Schizophr Bull</addtitle><date>1997</date><risdate>1997</risdate><volume>23</volume><issue>4</issue><spage>567</spage><epage>582</epage><pages>567-582</pages><issn>0586-7614</issn><eissn>1745-1701</eissn><abstract>This article reviews antipsychotic medication side effects, especially those that require the physician to discontinue or the patient to be noncompliant with otherwise useful medication. They include such common problems as extrapyramidal syndromes (dystonia, akathisia, drug-induced Parkinsonism, tardive dyskinesia), sedation, weight gain, and sexual dysfunction, as well as less frequent concerns, such as seizures, neuroleptic malignant syndrome, agranulocytosis, torsade de pointes, hepatitis, and dermatological and ophthalmological syndrome. The adverse events associated with some of the new antipsychotic drugs are included. Available information about individual susceptibility to side effects is addressed by syndrome.</abstract><cop>United States</cop><pub>National Institute of Mental Health</pub><pmid>9365996</pmid><doi>10.1093/schbul/23.4.567</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0586-7614 |
ispartof | Schizophrenia bulletin, 1997, Vol.23 (4), p.567-582 |
issn | 0586-7614 1745-1701 |
language | eng |
recordid | cdi_proquest_journals_614326033 |
source | MEDLINE; Oxford Academic Journals (OUP); Alma/SFX Local Collection; EZB Electronic Journals Library; EBSCOhost APA PsycARTICLES |
subjects | Antipsychotic Agents - adverse effects Drug Therapy Dyskinesia, Drug-Induced - etiology Extrapyramidal Symptoms Human Humans Neuroleptic Drugs Neuroleptic Malignant Syndrome - etiology Parkinson Disease, Secondary - chemically induced Patient Compliance Schizophrenia - drug therapy Seizures - chemically induced Sexual Dysfunctions, Psychological - chemically induced Side Effects (Drug) Torsades de Pointes - chemically induced |
title | Neuroleptic intolerance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A17%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroleptic%20intolerance&rft.jtitle=Schizophrenia%20bulletin&rft.au=Hansen,%20T%20E&rft.date=1997&rft.volume=23&rft.issue=4&rft.spage=567&rft.epage=582&rft.pages=567-582&rft.issn=0586-7614&rft.eissn=1745-1701&rft_id=info:doi/10.1093/schbul/23.4.567&rft_dat=%3Cproquest_cross%3E614326033%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=614326033&rft_id=info:pmid/9365996&rfr_iscdi=true |